BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9030377)

  • 1. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foscarnet for herpes.
    Posit Aware; 1995; ():5. PubMed ID: 11362667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
    Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
    J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
    Khurana RN; Charonis A; Samuel MA; Gupta A; Tawansy KA
    Med Sci Monit; 2005 Dec; 11(12):CS75-8. PubMed ID: 16319793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foscarnet effective in acyclovir-resistant herpes.
    Am Pharm; 1991 Nov; NS31(11):12. PubMed ID: 1836936
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acyclovir-resistant herpes exulcerans et persistens. Type II].
    Klammer M; Kuhn A; Ruzicka T; Stege H
    Hautarzt; 2003 Apr; 54(4):362-4. PubMed ID: 12669211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
    Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
    Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
    Hatchette T; Tipples GA; Peters G; Alsuwaidi A; Zhou J; Mailman TL
    Pediatr Infect Dis J; 2008 Jan; 27(1):75-7. PubMed ID: 18162946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.
    Moses SE; Osborne W; Valappil M; Collin M; Lee D; Waugh S; Jackson G; Parry CM; Crowley B
    J Clin Virol; 2011 Oct; 52(2):67-9. PubMed ID: 21665532
    [No Abstract]   [Full Text] [Related]  

  • 19. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study.
    Javaly K; Wohlfeiler M; Kalayjian R; Klein T; Bryson Y; Grafford K; Martin-Munley S; Hardy WD
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):301-6. PubMed ID: 10428108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.